ArticleCancer biology & therapy2014

Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.

Yvette M Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.